Trojanek JB, Michałkiewicz J, Grzywa-Czuba R, Jańczyk W, Gackowska L, Kubiszewska I, et al. Expression of matrix metalloproteinases and their tissue inhibitors in peripheral blood leukocytes and plasma of children with nonalcoholic fatty liver disease. Mediators Inflamm. 2020;8327945:1–14. https://doi.org/10.1155/2020/8327945.

Article  CAS  Google Scholar 

Lee SS, Byoun YS, Jeong SH, Woo BH, Jang ES, Kim JW, et al. Role of the PNPLA3 I148M polymorphism in nonalcoholic fatty liver disease and fibrosis in Korea. Dig Dis Sci. 2014;59(12):2967–74. https://doi.org/10.1007/s10620-014-3279-z.

Article  CAS  PubMed  Google Scholar 

O-charoenrat P, Khantapura P. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer. Oral Oncol. 2006;42(3):257–67. https://doi.org/10.1016/j.oraloncology.2005.07.008.

Article  CAS  PubMed  Google Scholar 

Mandal RK, Akhter N, Haque S, Panda AK, Mittal RD, Alqumber MAA. No correlation between TIMP2 -418 G>C polymorphism and increased risk of cancer: evidence from a meta-analysis. PLoS ONE. 2014;9(8): e88184. https://doi.org/10.1371/journal.pone.0088184.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Howard EW, Bullen EC, Banda MJ. Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of metalloproteinases-2. J Biol Chem. 1991;266(20):13070–5.

Article  CAS  PubMed  Google Scholar 

Chung GE, Shin E, Kwak MS. The association of genetic polymorphisms with nonalcoholic fatty liver disease in a longitudinal study. BMC Gastroenterol. 2020;20:344. https://doi.org/10.1186/s12876-020-01469-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dongiovanni P, Anstee Q, Valenti L. Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment. Curr Pharm Des. 2013;19(29):5219–38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eslam M, Valenti L, Romeo S. Genetics and epigenetics of NAFLD and NASH: clinical impact. J Hepatol. 2018;68(2):268–79.

Article  CAS  PubMed  Google Scholar 

Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, Boerwinkle E, Cohen JC, Hobbs HH. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008;40(12):1461–5. https://doi.org/10.1038/ng.257.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eslam M, Mangia A, Berg T, Chan HLY, Irving WL, Dore GJ, et al. Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes. Hepatol Baltim Md. 2016;64(1):34–46.

Article  CAS  Google Scholar 

Valenti L, Alisi A, Nobili V. Unraveling the genetics of fatty liver in obese children: additive effect of P446L GCKR and I148M PNPLA3 polymorphisms. Hepatology. 2012;55(3):661–3.

Article  PubMed  Google Scholar 

Li X, Liu C, Ran R, Liu G, Yang Y, Zhao W, Xie X, Li J. Matrix metalloproteinase family gene polymorphisms and lung cancer susceptibility: an updated meta-analysis. J Thorac Dis. 2020;12(3):349–62. https://doi.org/10.21037/jtd.2020.01.25.

Article  PubMed  PubMed Central  Google Scholar 

Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol. 1997;74(2):111–22.

CAS  PubMed  Google Scholar 

Zhou Y. Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes. Carcinogenesis. 2003;25(3):399–404.

Article  PubMed  Google Scholar 

Hirano K, Sakamoto T, Uchida Y, Morishima Y, Masuyama K, Ishii Y, et al. Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease. Eur Respir J. 2001;18(5):748–52.

Article  CAS  PubMed  Google Scholar 

Ma Y, Belyaeva OV, Brown PM, Fujita K, Valles K, Karki S, et al. 17-Beta hydroxysteroid dehydrogenase 13 is a hepatic retinol dehydrogenase associated with histological features of nonalcoholic fatty liver disease. Hepatol Baltim Md. 2019;69(4):1504–19.

Article  CAS  Google Scholar 

Wong Edward. Clinical laboratory diagnostics: use and assessment of clinical laboratory results. Lothar Thomas. Frankfurt/Main, Germany: TH-Books Verlagsgeselschaft, 1998, 1727 pp., $149.00. ISBN 3-9805215-4-0. Clin Chem. 1999;45(4):586–7.

Article  CAS  Google Scholar 

Mikołajczyk-Stecyna J, Korcz A, Gabriel M, Pawlaczyk K, Oszkinis G, Słomski R. Gene polymorphism -418 G/C of tissue inhibitor of metalloproteinases 2 is associated with abdominal aortic aneurysm. J Vasc Surg. 2015;61(5):1114–9.

Article  PubMed  Google Scholar 

Yang L, Gu HJ, Zhu HJ, Sun QM, Cong RH, Zhou B, et al. Tissue inhibitor of metalloproteinase-2 G-418C polymorphism is associated with an increased risk of gastric cancer in a Chinese population. Eur J Surg Oncol. 2008;34(6):636–41. https://doi.org/10.1016/j.ejso.2007.09.003.

Article  CAS  PubMed  Google Scholar 

Banday MZ, Sameer AS. Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study. Biosci Rep. 2019;39(5):BSR20190478. https://doi.org/10.1042/BSR20190478.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meissburger B, Stachorski L, Röder E, Rudofsky G, Wolfrum C. Tissue inhibitor of matrix metalloproteinase 1 (TIMP1) controls adipogenesis in obesity in mice and in humans. Diabetologia. 2011;54(6):1468–79. https://doi.org/10.1007/s00125-011-2093-9.

Article  CAS  PubMed  Google Scholar 

Tian J, Zhong R, Liu C, Tang Y, Gong J, Chang J, et al. Association between bilirubin and risk of non-alcoholic fatty liver disease based on a prospective cohort study. Sci Rep. 2016;6(1):31006. https://doi.org/10.1038/srep31006.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fung J, Lee CK, Chan M, Seto WK, Lai CL, Yuen MF. High prevalence of non-alcoholic fatty liver disease in the Chinese —results from the Hong Kong liver health census. Liver Int. 2015;35(2):542–9. https://doi.org/10.1111/liv.12619.

Article  PubMed  Google Scholar